Recent Activity

Loading...

GMED

Globus Medical Inc Class A · NYSE

Performance

+23.98%

1W

+19.1%

1M

+16.82%

3M

+33.64%

6M

+15.84%

YTD

+6.12%

1Y

Profile

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional pain management solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. The company also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, it distributes human cell, tissue, and cellular and tissue-based products. The company sells its products through direct or distributor sales presence, as well as its hip and knee products primarily through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.

Investment Analysis Report: GMED

Overview

In this investment analysis report, we will delve into the financial statements of GMED, a company operating in the Health Technology sector with a market capitalization of $6.21 billion. We will analyze the company's financial health, earnings and revenue growth, profitability, operating margin, operati...

See more ...

Technical Analysis of GMED 2024-05-03

Overview:

In the last 5 trading days, GMED has shown mixed signals across various technical indicators. The stock price has fluctuated within a certain range, with some indicators suggesting potential weakness while others hint at possible strength. By analyzing trend, momentum, volatility, and volume indicators, we can gain a comprehensive unde...

See more ...

Recent News & Updates